The effectiveness of fluoxetine in the treatment of depressio

Not Applicable

• Conditions: Major Depression.; Mood disorder due to known physiological condition with major depressive-like episode; F06.32

• Registration Number: IRCT20220706055386N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Age 4-6 years old
The diagnosis of depression based on the DSM-V criteria related to the diagnosis of depression in preschool children for the patient must be confirmed by a psychiatrist (severity of depression will be obtained based on a high score by the subject on the revised parent anxiety-depression scale = a score higher than 25 ).
No other psychiatric disorders
Parents' consent to children's participation in this study
No history of previous use of fluoxetine or other psychiatric drugs
Not taking drugs that interfere with fluoxetine
Not having separate families (single-parent children, children of divorce, having a stepmother or stepfather, or the death of parents)

Exclusion Criteria

Lack of parental consent to continue studying at any time of the study
Drug side effects caused by fluoxetine use

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Major Depression. Timepoint: Measurement of major depression at the beginning of the study (before the start of the intervention) and the fourth week and three months after starting the fluoxetine drug. Method of measurement: The Revised Child Anxiety and Depression Scales–Parent Version (RCADS-P).